SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Neurex Corporation
An SI Board Since December 1996
Posts SubjectMarks Bans Symbol
449 4 0 NXCO
Emcee:  ChinuSFO Type:  Unmoderated
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
24 it was $2.00 or so in 1995. what do you think was WL reasoning in selling so maBill Tomko-1/21/1997
23 have you seen this? How could they have rec'd it at 2? Haven't seen tcl-1/21/1997
22 Thanks, but didn't help, only general info. >Menlo Park, CA, April 6, 1Miljenko Zuanic-1/16/1997
21 take a look at the following site: recap.com I don't know how current thecl-1/15/1997
20 To all! Does anybody has data on phase III clinical trials of Corlopam for bloMiljenko Zuanic-1/15/1997
19 Thank You very much. i will review and discuss with some of the tech. advisers Bill Tomko-1/14/1997
18 This is the grand-daddy of them all, in PNAS... Title: A selective N-tycl-1/14/1997
17 No abstract for this one, but relates to ischemia... Title: The omega-ccl-1/14/1997
16 Neural protection after ischemia... Title: A selective N-type Ca(2+)-chcl-1/14/1997
15 This one says snx-111 is neural protective... Title: Administration of cl-1/14/1997
14 Bill, I am not familiar with txb and ribi, but I'll look into it when I getcl-1/14/1997
13 Yes, please post all tech. info and/or lit. you can find. Beyond pain mgt. thisBill Tomko-1/14/1997
12 Sorry to have confused you, Bill. I wasn't in the right state of mind I gucl-1/13/1997
11 I am not a technical expert----so, if my inquiry just exposes my ignorance, pleBill Tomko-1/13/1997
10 want more? I have a few left.. Title: A selective N-type calcium channcl-1/10/1997
9 now I have a bad day that's what biotech can do to you! and this thread icl-1/10/1997
8 Neurex to present at the Healthcare Conference by Hambrecht & Quist, tomorrcl-1/7/1997
7 All, guess what, there are 3 neurex discussion groups in SI. Since the subjeccl-1/6/1997
6 The 1997 will be a great year for Neurex. It is expected to have at least tJeffers Hughes-1/5/1997
5 Chuck, Their blood pressure control drug, Corlopam was filed (NDA)in June of &James Silverman-1/4/1997
4 The one-year target of 40 has also been made by Montgomery Securities analystJifan Hu-1/4/1997
3 Hi Regarding SNX-111 Is it true that they won't submit to the FDA (at leacl-1/4/1997
2 Neurex has 2 drugs in advanced Phase 3 trials and the results for both so far aChinuSFO-1/3/1997
1 Hi, who's Crutendden Roth? What's the basis for the 40 projection? Thcl-1/3/1997
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):